Stepan (SCL) vs Solesence (SLSN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Stepan (SCL) has outperformed Solesence (SLSN) over the past year, gaining 43.8% versus a loss of 36.2%. Over five years, SCL leads with a -46.3% price change compared with -62.2% for SLSN. Stepan is the larger company by market cap ($1.44 billion vs $99.6 million), about 14.5 times the size, while Solesence is growing revenue faster (+18.6% vs +7.0%).
On valuation, Solesence trades at a lower trailing P/E (47.0x vs 334.1x for Stepan). Stepan pays a dividend yielding 2.49%, while Solesence does not currently pay one. Solesence converts more of its revenue into profit, with a net margin of 4.5% versus 2.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SCL | SLSN |
|---|---|---|
| Share price | $63.48 | $1.41 |
| Market cap | $1.44B | $99.61M |
| 1-day change | -2.34% | -4.73% |
| YTD return | +34.04% | -11.88% |
| 1-year return | +43.85% | -36.20% |
| 5-year return | -46.34% | -62.20% |
| P/E ratio (TTM) | 334.11 | 47.00 |
| Forward P/E | 18.03 | — |
| EPS (TTM) | $0.19 | $0.03 |
| Dividend yield | 2.49% | 0.00% |
| Annual dividend | $1.58 | $0.00 |
| Revenue (latest FY) | $2.33B | $62.06M |
| Revenue growth (YoY) | +6.96% | +18.56% |
| Net income (latest FY) | $46.90M | $2.81M |
| Gross margin | 11.57% | 27.52% |
| Operating margin | 3.37% | 4.17% |
| Net margin | 2.01% | 4.53% |
| 52-week high | $72.67 | $2.30 |
| 52-week low | $43.00 | $0.61 |
| Distance from 52-week high | -12.65% | -38.70% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +33.90% | — |
| Average volume | 152.47K | 392.50K |
| Shares outstanding | 22.73M | 70.65M |
| Employees | 2,328 | 115 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Package Goods/Cosmetics | Package Goods/Cosmetics |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Stepan is about 14.5 times larger than Solesence by market value ($1.44B vs $99.61M).
- SCL has outperformed SLSN by 80.0 percentage points over the past year.
- Stepan trades at a higher earnings multiple (334.1x vs 47.0x trailing P/E).
- Stepan offers a meaningfully higher dividend yield (2.49% vs 0.00%).
- Solesence grew revenue faster in its latest fiscal year (+18.56% vs +6.96%).
About Stepan
SCL stock →Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally. It operates through three segments: Surfactants, Polymers, and Specialty Products.
Consumer Discretionary · Package Goods/Cosmetics · 2,328 employees
About Solesence
SLSN stock →Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients.
Consumer Discretionary · Package Goods/Cosmetics · 115 employees
SCL vs SLSN FAQ
Which is bigger, Stepan or Solesence?
Stepan (SCL) is larger, with a market capitalization of $1.44B compared with $99.61M for Solesence (SLSN).
Which stock has performed better over the past year, SCL or SLSN?
SCL returned +43.85% over the past 12 months, compared with -36.20% for SLSN (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, SCL or SLSN?
SLSN has the lower trailing P/E at 47.0, versus 334.1 for SCL. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Stepan or Solesence?
Stepan pays a dividend yielding 2.49%, while Solesence does not currently pay a regular dividend.
Are Stepan and Solesence in the same industry?
Yes. Both are classified in the Package Goods/Cosmetics industry within the Consumer Discretionary sector.